Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2016, Article ID 6304385, 10 pages
http://dx.doi.org/10.1155/2016/6304385
Research Article

The Characteristics Variation of Hepatic Progenitors after TGF-β1-Induced Transition and EGF-Induced Reversion

1Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing Key Laboratory of Translational Medicine in Liver Cirrhosis & National Clinical Research Center of Digestive Diseases, Beijing 100050, China
2Municipal Laboratory for Liver Protection and Regulation of Regeneration, Capital Medical University, Beijing 100050, China

Received 23 November 2015; Accepted 11 January 2016

Academic Editor: Yun-Wen Zheng

Copyright © 2016 Ping Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. J. Williams, A. D. Clouston, and S. J. Forbes, “Links between hepatic fibrosis, ductular reaction, and progenitor cell expansion,” Gastroenterology, vol. 146, no. 2, pp. 349–356, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Kaur, H. Siddiqui, and M. H. Bhat, “Hepatic progenitor cells in action,” The American Journal of Pathology, vol. 185, no. 9, pp. 2342–2350, 2015. View at Publisher · View at Google Scholar
  3. K. N. Lowes, B. A. Brennan, G. C. Yeoh, and J. K. Olynyk, “Oval cell numbers in human chronic liver diseases are directly related to disease severity,” The American Journal of Pathology, vol. 154, no. 2, pp. 537–541, 1999. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Libbrecht, V. Desmet, B. Van Damme, and T. Roskams, “Deep intralobular extension of human hepatic ‘progenitor cells’ correlates with parenchymal inflammation in chronic viral hepatitis: can ‘progenitor cells’ migrate?” Journal of Pathology, vol. 192, no. 3, pp. 373–378, 2000. View at Google Scholar · View at Scopus
  5. R. J. Isfort, D. B. Cody, W. G. Richards, B. K. Yoder, J. E. Wilkinson, and R. P. Woychik, “Characterization of growth factor responsiveness and alterations in growth factor homeostasis involved in the tumorigenic conversion of mouse oval cells,” Growth Factors, vol. 15, no. 2, pp. 81–94, 1998. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Massagué, “TGFβ in Cancer,” Cell, vol. 134, no. 2, pp. 215–230, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. L. N. Nguyen, M. H. Furuya, L. A. Wolfraim et al., “Transforming growth factor-β differentially regulates oval cell and hepatocyte proliferation,” Hepatology, vol. 45, no. 1, pp. 31–41, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Wang, T. Liu, M. Cong et al., “Expression of extracellular matrix genes in cultured hepatic oval cells: an origin of hepatic stellate cells through transforming growth factor beta?” Liver International, vol. 29, no. 4, pp. 575–584, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Wu, J. Ding, C. Chen et al., “Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer development,” Hepatology, vol. 56, no. 6, pp. 2255–2267, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. J. A. Cienfuegos, F. Rotellar, J. Baixauli, F. Martínez-Regueira, F. Pardo, and J. L. Hernández-Lizoáin, “Liver regeneration—the best kept secret. A model of tissue injury response,” Revista Espanola de Enfermedades Digestivas, vol. 106, no. 3, pp. 171–194, 2014. View at Google Scholar · View at Scopus
  11. G. Huang, G. E. Besner, and D. R. Brigstock, “Heparin-binding epidermal growth factor-like growth factor suppresses experimental liver fibrosis in mice,” Laboratory Investigation, vol. 92, no. 5, pp. 703–712, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Takemura, Y. Yoshida, S. Kiso et al., “Conditional loss of heparin-binding EGF-like growth factor results in enhanced liver fibrosis after bile duct ligation in mice,” Biochemical and Biophysical Research Communications, vol. 437, no. 2, pp. 185–191, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Wang, A. T. Yang, M. Cong et al., “EGF suppresses the initiation and drives the reversion of TGF-β1-induced transition in hepatic oval cells showing the plasticity of progenitor cells,” Journal of Cellular Physiology, vol. 230, no. 10, pp. 2362–2370, 2015. View at Publisher · View at Google Scholar
  14. P. Wang, M. Cong, T.-H. Liu et al., “Primary isolated hepatic oval cells maintain progenitor cell phenotypes after two-year prolonged cultivation,” Journal of Hepatology, vol. 53, no. 5, pp. 863–871, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Martínez-Palacián, G. del Castillo, A. Suárez-Causado et al., “Mouse hepatic oval cells require Met-dependent PI3K to impair TGF-β-induced oxidative stress and apoptosis,” PLoS ONE, vol. 8, no. 1, Article ID e53108, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. L. A. Aparicio, M. Blanco, R. Castosa et al., “Clinical implications of epithelial cell plasticity in cancer progression,” Cancer Letters, vol. 366, no. 1, pp. 1–10, 2015. View at Publisher · View at Google Scholar